IMMUNEMED
ImmuneMed offers the development of anti-viral treatment and diagnosis for infectious diseases.
IMMUNEMED
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2000-01-01
Address:
Chuncheon, Kangwon-do, South Korea
Country:
South Korea
Website Url:
http://www.immunemed.co.kr
Total Employee:
51+
Status:
Active
Contact:
82-33-258-6551
Official Site Inspections
http://www.immunemed.co.kr Semrush global rank: 5.41 M Semrush visits lastest month: 1.56 K
- Host name: 220.73.130.38
- IP address: 220.73.130.38
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "ImmuneMed"
ImmuneMed
[Press Release] ImmuneMed's hzVSF-v13, COVID-19 clinical trials accelerate development of the treatment. 2021-01-08. Press Release. COVID-19 Phase 2 Clinical Study Approval (Italy), …See details»
Company Introduction | ImmuneMed
ImmuneMed discovers and develops burfiralimab, an antiviral substance. Various chemical drugs and interferon are used as antiviral drugs, but there are many limitations in clinical practice. …See details»
ImmuneMed, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for ImmuneMed, Inc. of Seoul, Seoul. Get the latest business insights from Dun & Bradstreet.See details»
ImmuneMed Inc. Overview | SignalHire Company Profile
Organization Website: immunemed.co.kr : Phone Number +82 332541669: ImmuneMed Inc. industries Biotech: Headquarters Location: 32 Soyangang-ro, Chooncheon, Gangwon-do, …See details»
ImmuneMed Inc. - Company Profile & Staff Directory - ContactOut
32 Soyangang-ro, Room#2-2, Bldg#3, BioTown, Chooncheon, Gangwon-do 24232, KR Information Clinical-stage Biopharmaceutical Company developing burfiralimab against …See details»
ImmuneMed Inc. - Company Profile
ImmuneMed Inc. promises to become a world-trusted company based on creative high-tech intensive research and sound management. Our mission is on human health and welfare in …See details»
ImmuneMed Company Profile 2024: Valuation, Funding
Www.immunemed.co.kr. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 11th floor, KD70 Building; ... Multi-Asset Asset …See details»
Antiviral Agent - ImmuneMed
Most of us experienced the disease progresses due to excessive inflammation such as a cytokine storm in the COVID-19 pandemic, ImmuneMed expects to be able to pioneer a new antiviral …See details»
Immunemed,inc., #2-2, 32, Soyanggang-ro, - kr.kompass.com
Activity and products #Keyword COVID-19, RAPID, TEST, KIT, DIAGNOSTIC, LEPTOSPIRA, DENGUE #Company Introduction The Novel Conceptual Drug Development through …See details»
ImmuneMed - Crunchbase Company Profile & Funding
Who invested in ImmuneMed? ImmuneMed is funded by UTC Investment Co.. When was the last funding round for ImmuneMed? ImmuneMed closed its last funding round on Jan 1, 2004 from …See details»
ImmuneMed Inc. - LinkedIn
ImmuneMed Inc. | 162 followers on LinkedIn. ImmuneMed is specialized in the development of innovative treatments for infectious and inflammatory diseases. | Clinical-stage …See details»
ImmuneMed: lifting the burden of infectious disease - Nature
ImmuneMed, Inc. Sungman Park, Director of Research Institute, ImmuneMed, Inc., Chuncheon, Gangwon-do, Republic of Korea, Tel: +82 10 4981 0417, www.immunemed.co.krSee details»
Mission & Business Strategy - ImmuneMed
Mission Contribution to the healthy life of mankind liberated from infectious diseases Vision Global biotech specializing in treatment of infectious diseasesSee details»
ImmuneMed - Products, Competitors, Financials, Employees, …
ImmuneMed focuses on the research and development of antiviral cytokine technology done using various techniques, such as virus culture, protein purification, RT-PCR, gene cloning, …See details»
Immunemed – Funding, Valuation, Investors, News - Parsers VC
Essential stats, news, real-time insights on Immunemed. Connect with decision makers, founders, investors. Explore valuation, funding rounds, reviews.See details»
ImmuneMed discovers endogenous broad-spectrum antiviral drug …
Sungman Park, Director of Research Institute, ImmuneMed, Inc., Chuncheon, Republic of Korea, Tel: +82-33-258-6551, Website: www.immunemed.co.kr ImmuneMed has discovered an …See details»
Pipeline - ImmuneMed
Headquarter. ㆍ Business Registration : 221-81-16466. ㆍ Address : 11F, KD70 Building, 4, Jeongui-ro 8-gil, Songpa-gu, Seoul 05836 Republic of KoreaSee details»
ImmuneMed: lifting the burden of infectious disease
ImmuneMed has identified specific antigens from Salmonella enterica serovar Typhi, which causes typhoid fever, which is being developed into a diagnostic test. Sungman Park, Director …See details»
CEO Greeting | ImmuneMed
Headquarter. ㆍ Business Registration : 221-81-16466. ㆍ Address : 11F, KD70 Building, 4, Jeongui-ro 8-gil, Songpa-gu, Seoul 05836 Republic of KoreaSee details»
Press Release | ImmuneMed
Dec 21, 2020 Headquarter. ㆍ Business Registration : 221-81-16466. ㆍ Address : 11F, KD70 Building, 4, Jeongui-ro 8-gil, Songpa-gu, Seoul 05836 Republic of KoreaSee details»